{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:02:26Z","timestamp":1759017746975,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T00:00:00Z","timestamp":1312848000000},"content-version":"vor","delay-in-days":161,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.leukres.2010.07.011","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T04:31:33Z","timestamp":1281414693000},"page":"317-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The use of imatinib mesylate has no adverse effects on the heart function. Results of a pilot study in patients with chronic myeloid leukemia"],"prefix":"10.1016","volume":"35","author":[{"given":"Milena Soriano","family":"Marcolino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Luiz","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelma C.D.","family":"Clementino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do Carmo P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia M.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena C.R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique N.S.","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel L.","family":"Geleijnse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.07.011_bib0005","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European Leukemianet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2006\/434761","article-title":"Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment","volume":"20","author":"Blackstein","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0015","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1200\/JCO.2003.12.154","article-title":"Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study","volume":"21","author":"Hahn","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm1446","article-title":"Cardiotoxicity of the cancer therapeutic agent imatinib mesylate","volume":"12","author":"Kerkel\u00e4","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2010.07.011_bib0025","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2007-01-070144","article-title":"Congestive heart failure is a rare event in patients receiving imatinib therapy","volume":"110","author":"Atallah","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.011_bib0030","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ejca.2007.01.018","article-title":"Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: analysis of EORTC-ISG-AGITG study 62005","volume":"43","author":"Verweij","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2010.07.011_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nm0107-13a","article-title":"In reply to \u2018Cardiotoxicity of the cancer therapeutic agent imatinib mesylate\u2019","volume":"13","author":"Hatfield","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2010.07.011_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2005.11.014","article-title":"BNP as a marker of the heart failure in the treatment of imatinib mesylate","volume":"243","author":"Park","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.leukres.2010.07.011_bib0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.leukres.2007.08.016","article-title":"Cardiac events in imatinib mesylate-treated chronic myeloid leukemia patients: a single institution experience","volume":"32","author":"Breccia","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.07.011_bib0050","article-title":"Atypical cardiac manifestation of hypereosinophilic syndrome and reversible cardiotoxicity to imatinib","author":"Garcia-Alvarez","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0055","article-title":"Congestive heart failure during imatinib mesylate treatment","author":"Turrisi","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/annonc\/mdm468","article-title":"Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity","volume":"19","author":"Perik","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0065","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.leukres.2008.03.020","article-title":"An evaluation of the cardiotoxicity of imatinib mesylate","volume":"32","author":"Ribeiro","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.07.011_bib0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukaemia","volume":"370","author":"Hehlmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2010.07.011_bib0075","doi-asserted-by":"crossref","first-page":"pe510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"year":"1994","series-title":"Diagnostic and Statistical Manual of Mental Disorders \u2013 DSM IV","author":"American Psychiatric Association","key":"10.1016\/j.leukres.2010.07.011_bib0080"},{"year":"1998","series-title":"Clinical electrocardiography: a textbook","author":"Bayes de Luna","key":"10.1016\/j.leukres.2010.07.011_bib0085"},{"key":"10.1016\/j.leukres.2010.07.011_bib0090","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.leukres.2010.07.011_bib0095","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0735-1097(98)00345-3","article-title":"New Doppler echocardiographic applications for the study of diastolic function","volume":"32","author":"Garcia","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0100","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0735-1097(97)00344-6","article-title":"Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures","volume":"30","author":"Nagueh","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(01)01744-2","article-title":"Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea","volume":"39","author":"Morrison","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.echo.2006.08.023","article-title":"Non-Doppler two-dimensional strain imaging by echocardiography \u2013 from technical considerations to clinical applications","volume":"20","author":"Perk","year":"2007","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.leukres.2010.07.011_bib0115","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1067\/j.echo.2003.09.004","article-title":"Clinical applications of strain rate imaging","volume":"16","author":"Yip","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.leukres.2010.07.011_bib0120","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.echo.2004.06.019","article-title":"Two-dimensional strain \u2013 a novel software for real-time quantitative echocardiographic assessment of myocardial function","volume":"17","author":"Leitman","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.leukres.2010.07.011_bib0125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcmg.2007.12.007","article-title":"Myocardial strain measurement with 2-dimensional speckle-tracking echocardiography: definition of normal range","volume":"2","author":"Marwick","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.leukres.2010.07.011_bib0130","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.07.011_bib0135","first-page":"1086","article-title":"American society of echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.leukres.2010.07.011_bib0140","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/01.CIR.0000130926.51766.CC","article-title":"Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy","volume":"109","author":"Cardinale","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.leukres.2010.07.011_bib0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ajh.21157","article-title":"Brain natriuretic peptide level as marker of cardiac function in imatinib-treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy","volume":"83","author":"Tiribelli","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0150","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/02841860903229124","article-title":"Cardiotoxicity induced by tyrosine kinase inhibitors","volume":"48","author":"Orphanos","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.leukres.2010.07.011_bib0155","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.1182\/blood-2008-11-186817","article-title":"Phase 3 study of dasatinib 140mg once daily versus 70mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up","volume":"113","author":"Kantarjian","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.011_bib0160","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2010.07.011_bib0165","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.07.011_bib0170","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.99.3.557","article-title":"Cardiotoxicity of interferon. A review of 44 cases","volume":"99","author":"Sonnenblick","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.leukres.2010.07.011_bib0175","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1536\/ihj.37.905","article-title":"Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C","volume":"37","author":"Teragawa","year":"1996","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.leukres.2010.07.011_bib0180","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.leukres.2008.02.023","article-title":"Improvement of cardiac function, mitral regurgitation and pulmonary hypertension in a patient with chronic eosinophilic leukemia (CEL) after low dose imatinib therapy","volume":"32","author":"Krauth","year":"2008","journal-title":"Leuk Res"},{"issue":"4 Suppl. A","key":"10.1016\/j.leukres.2010.07.011_bib0185","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.leukres.2010.07.011_bib0190","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ehj.2004.06.038","article-title":"Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study","volume":"25","author":"Bleumink","year":"2004","journal-title":"Eur Heart J"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610003541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610003541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:57:10Z","timestamp":1758934630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610003541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0145212610003541"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.07.011","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of imatinib mesylate has no adverse effects on the heart function. Results of a pilot study in patients with chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2010.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}